BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4473046)

  • 1. Generation of C5-derived lysosomal enzyme-releasing activity (C5a) by lysates of leukocyte lysosomes.
    Goldstein IM; Weissmann G
    J Immunol; 1974 Nov; 113(5):1583-8. PubMed ID: 4473046
    [No Abstract]   [Full Text] [Related]  

  • 2. Lysosomal enzyme release from human leukocytes: mediation by the alternate pathway of complement activation.
    Goldstein IM; Brai M; Osler AG; Weissmann G
    J Immunol; 1973 Jul; 111(1):33-7. PubMed ID: 4197335
    [No Abstract]   [Full Text] [Related]  

  • 3. The inhibition of phagocytosis and facilitation of exocytosis in rabbit polymorphonuclear leukocytes by cytochalasin B.
    Davies P; Fox RI; Polyzonis M; Allison AC; Haswell AD
    Lab Invest; 1973 Jan; 28(1):16-22. PubMed ID: 4569931
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on crystal-induced chemotactic factor. II. Role of phagocytosis.
    Spilberg I; Gallacher A; Mendell B
    J Lab Clin Med; 1975 Apr; 85(4):631-6. PubMed ID: 1120930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ability of chemotactic factors to induce lysosomal enzyme release. I. The characteristics of the release, the importance of surfaces and the relation of enzyme release to chemotactic responsiveness.
    Becker EL; Showell HJ; Henson PM; Hsu LS
    J Immunol; 1974 Jun; 112(6):2047-54. PubMed ID: 4596695
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanisms of lysosomal enzyme release from leukocytes. IV. Interaction of monosodium urate crystals with dogfish and human leukocytes.
    Hoffstein S; Weissmann G
    Arthritis Rheum; 1975; 18(2):153-65. PubMed ID: 48382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ability of chemotactic factors to induce lysosomal enzyme release. II. The mechanism of release.
    Becker EL; Showell HJ
    J Immunol; 1974 Jun; 112(6):2055-62. PubMed ID: 4825785
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of lysosomal enzyme release from leukocytes exposed to immune complexes and other particles.
    Weissmann G; Zurier RB; Spieler PJ; Goldstein IM
    J Exp Med; 1971 Sep; 134(3 Pt 2):149s-165s. PubMed ID: 5570749
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of lectins on lysosomal enzyme release from neutrophilic leukocytes.
    Hawkins D
    J Immunol; 1974 Dec; 113(6):1864-71. PubMed ID: 4430834
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential effects of antibodies to rat liver tritosome proteins on the activity of some lysosomal hydrolases in vitro.
    Pajdak W; Koj A; Ptak W
    Folia Biol (Krakow); 1975; 23(1):21-31. PubMed ID: 50953
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms of lysosomal enzyme release from human leukocytes: microtubule assembly and membrane fusion induced by a component of complement.
    Goldstein I; Hoffstein S; Gallin J; Weissmann G
    Proc Natl Acad Sci U S A; 1973 Oct; 70(10):2916-20. PubMed ID: 4355374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochalasin B: effect on lysosomal enzyme release from human leukocytes.
    Zurier RB; Hoffstein S; Weissmann G
    Proc Natl Acad Sci U S A; 1973 Mar; 70(3):844-8. PubMed ID: 4351807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective release of lysosomal hydrolases from phagocytic cells by cytochalasin B.
    Davies P; Allison AC; Haswell AD
    Biochem J; 1973 May; 134(1):33-41. PubMed ID: 4737379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. II. Evidence for involvement of C1 and components of the alternate complement pathway.
    May JE; Frank MM
    J Immunol; 1973 Dec; 111(6):1668-76. PubMed ID: 4750863
    [No Abstract]   [Full Text] [Related]  

  • 15. Neutrophilic leukocytes in immunologic reactions: evidence for the selective release of lysosomal constituents.
    Hawkins D
    J Immunol; 1972 Feb; 108(2):310-7. PubMed ID: 5049087
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative phagocytosis by neutrophils. II. Release of the C5-cleaving enzyme and inhibition of phagocytosis by rheumatoid factor.
    Ward PA; Zvaifler NJ
    J Immunol; 1973 Dec; 111(6):1777-82. PubMed ID: 4201556
    [No Abstract]   [Full Text] [Related]  

  • 17. Passive immune lysis with chromic chloride-treated erythrocytes.
    Perucca PJ; Faulk WP; Fudenberg HH
    J Immunol; 1969 Apr; 102(4):812-20. PubMed ID: 5768191
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. I. Antibody and serum requirements.
    May JE; Frank MM
    J Immunol; 1973 Dec; 111(6):1671-7. PubMed ID: 4750864
    [No Abstract]   [Full Text] [Related]  

  • 19. Release of vasoactive amines from rabbit platelets induced by antiplatelet antibody in the presence and absence of complement.
    Henson PM
    J Immunol; 1970 Apr; 104(4):924-34. PubMed ID: 4191863
    [No Abstract]   [Full Text] [Related]  

  • 20. Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes.
    Chenoweth DE; Hugli TE
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3943-7. PubMed ID: 279010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.